M. Manicone

Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer

G. Timon, A. Botti, C. Iotti, 2021, Strahlentherapie und Onkologie.

Effectiveness and safety of "real" concurrent stereotactic radiotherapy and immunotherapy in metastatic solid tumors: a systematic review.

S. Buti, A. Sikokis, G. Ceccon, 2019, Critical reviews in oncology/hematology.

Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience

F. Merli, L. Marcheselli, D. Albano, 2021, Journal of cachexia, sarcopenia and muscle.

Emostatic-palliative radiotherapy in vescical carcinoma: two case reports

R. Rossi, S. Buti, P. Losardo, 2019, AboutOpen.

Adenoid Cystic Carcinoma/Basal Cell Carcinoma of the Prostate: Overview and Update on Rare Prostate Cancer Subtypes

M. Augugliaro, L. Giaccherini, A. Botti, 2022, Current oncology.

42. The role of emphysema on radiation-induced lung toxicity and the feasibility of a “functional treatment plan”

R. Rossi, C. Ghetti, G. Benecchi, 2018, Physica medica (Testo stampato).

Good clinical practice and the use of hypofractionation radiation schedules as weapons to reduce the risk of COVID-19 infections in radiation oncology unit: A mono-institutional experience

L. Giaccherini, A. Botti, C. Iotti, 2023, Journal of cancer research and therapeutics.